About Statutes

This page accesses the Code of Maryland (Statutes) and the Maryland Municipal Charters and Resolutions as compiled and maintained by the Department of Legislative Services.

The Code is arranged by and organized into “Articles” (e.g. Transportation Article), which are further subdivided into “titles”, “subtitles”, “sections”, “subsections”, “paragraphs”, subparagraphs”, etc.

Note that the “official” compilation of the laws (Chapters) enacted at each session of the General Assembly is published by the State as the “Laws of Maryland”, commonly referred to as the “Session Laws”. The Session Laws for each session are compiled chronologically by chapter number and serve as the source law from which the statutes accessed here are derived.

While the “Laws of Maryland” (Session Laws) constitute the official laws of the State, this Code and the annotated versions noted below are accepted as “evidence” of the law in all State courts and by all public offices and officials (See § 10-201 of the Courts & Judicial Proceedings Article). However, in the event of a conflict between the Code and the Session Laws, the Session Laws prevail.

Note: Annotated versions of the Code, published by LexisNexis and West, are available in book and online formats. These Annotated Codes include references to case law, related citations, and explanatory notations.

The Municipal Charters are updated each year by incorporating all charter resolutions received by the Department through May 31 of that year. Individual Municipal Resolutions are published to the General Assembly website as they are received by the Department.



Statute Text

ati520456.tmp
Article - Criminal Law
§5–402.  
(a)   Schedule I consists of each controlled dangerous substance:
(1)   listed in this section;
(2)   added to Schedule I by the Department under § 5-202(b) of this title; or
(3)   designated as a Schedule I controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.
(b)    (1)   These substances are listed in Schedule I:
(i)   acetylmethadol;
(ii)   alfentanil;
(iii)   allylprodine;
(iv)   alphacetylmethadol, except levoalphacetylmethadol;
(v)   alphameprodine;
(vi)   alphamethadol;
(vii)   benzethidine;
(viii)   betacetylmethadol;
(ix)   betameprodine;
(x)   betamethadol;
(xi)   betaprodine;
(xii)   clonitazene;
(xiii)   dextromoramide;
(xiv)   dextrorphan;
(xv)   diampromide;
(xvi)   diethylthiambutene;
(xvii)   dimenoxadol;
(xviii)   difenoxin;
(xix)   dimepheptanol;
(xx)   dimethylthiambutene;
(xxi)   dioxaphetyl butyrate;
(xxii)   dipipanone;
(xxiii)   ethylmethylthiambutene;
(xxiv)   etonitazene;
(xxv)   etoxeridine;
(xxvi)   furethidine;
(xxvii)   hydroxypethidine;
(xxviii)   ketobemidone;
(xxix)   levomoramide;
(xxx)   levophenacylmorphan;
(xxxi)   morpheridine;
(xxxii)   noracymethadol;
(xxxiii)   norlevorphanol;
(xxxiv)   normethadone;
(xxxv)   norpipanone;
(xxxvi)   phenadoxone;
(xxxvii)   phenampromide;
(xxxviii)   phenomorphan;
(xxxix)   phenoperidine;
(xl)   piritramide;
(xli)   proheptazine;
(xlii)   properidine;
(xliii)   propiram;
(xliv)   racemoramide; and
(xlv)   trimeperidine.
(2)   Unless specifically excepted under this subtitle, an isomer, ester, ether, or salt of a substance listed in this subsection or a salt of the isomer, ester, or ether is a substance listed in Schedule I if the existence of the isomer, ester, ether, or salt is possible within the specific chemical designation.
(c)    (1)   These opium derivatives are substances listed in Schedule I:
(i)   acetorphine;
(ii)   acetyldihydrocodeine;
(iii)   acetylocodone;
(iv)   benzylmorphine;
(v)   codeine methylbromide;
(vi)   codeine-N-oxide;
(vii)   codoxime;
(viii)   cyprenorphine;
(ix)   desomorphine;
(x)   dihydromorphine;
(xi)   drotebanol;
(xii)   ethylmorphine methyliodide;
(xiii)   etorphine;
(xiv)   etorphine 3-methylether;
(xv)   heroin;
(xvi)   hydromorphinol;
(xvii)   methyldesorphine;
(xviii)   methyldihydromorphinone;
(xix)   methylhydromorphine;
(xx)   morphine methylbromide;
(xxi)   morphine methylchloride;
(xxii)   morphine methylsulfonate;
(xxiii)   morphine-N-oxide;
(xxiv)   myrophine;
(xxv)   nicocodeine;
(xxvi)   nicodicodine;
(xxvii)   nicomorphine;
(xxviii)   norcodeine;
(xxix)   normorphine;
(xxx)   pholcodine; and
(xxxi)   thebacon.
(2)   Unless specifically excepted under this subtitle, a salt, isomer, or salt of an isomer of a substance listed in this subsection is a Schedule I substance if the existence of the salt, isomer, or salt of an isomer is possible within the specific chemical designation.
(d)    (1)   A material, compound, mixture, or preparation that contains any of the following hallucinogenic or hallucinogenic–like substances is a substance listed in Schedule I:
(i)   bufotenine;
(ii)   diethyltryptamine;
(iii)   dimethyltryptamine;
(iv)   4–methyl–2, 5–dimethoxyamphetamine;
(v)   ibogaine;
(vi)   lysergic acid diethylamide;
(vii)   marijuana;
(viii)   mescaline;
(ix)   peyote;
(x)   psilocybin;
(xi)   psilocyn;
(xii)   tetrahydrocannabinol;
(xiii)   thiophene analog of phencyclidine;
(xiv)   2, 5–dimethoxyamphetamine;
(xv)   4–bromo–2, 5–dimethoxyamphetamine;
(xvi)   4–methoxyamphetamine;
(xvii)   3, 4–methylenedioxyamphetamine;
(xviii)   3, 4–methylenedioxymethamphetamine (MDMA);
(xix)   5–methoxy–3, 4–methylenedioxyamphetamine;
(xx)   3, 4, 5–trimethoxyamphetamine;
(xxi)   N–methyl–3–piperidyl benzilate;
(xxii)   N–ethyl–3–piperidyl benzilate;
(xxiii)   N–ethyl–1–phenylcyclohexylamine;
(xxiv)   1–(1–phenylcyclohexyl)–pyrrolidine;
(xxv)   1–(1–(2–thienyl)–cyclohexyl)–piperidine;
(xxvi)   1–methyl–4–phenyl–4–propionoxypiperidine (MPPP);
(xxvii)   1–(2–phenylethyl)–4–phenyl–4–acetyloxypiperidine (PEPAP);
(xxviii)   3, 4–methylenedioxymethcathinone (methylone);
(xxix)   3, 4–methylenedioxypyrovalerone (MDPV);
(xxx)   4–methylmethcathinone (mephedrone);
(xxxi)   4–methoxymethcathinone (methedrone);
(xxxii)   4–fluoromethcathinone (flephedrone);
(xxxiii)   3–fluoromethcathinone (3–FMC); and
(xxxiv)   cannabimimetic agents.
(2)   Unless specifically excepted under this subtitle, a salt, isomer, or salt of an isomer of a substance listed in this subsection is a substance listed in Schedule I if the existence of the salt, isomer, or salt of an isomer is possible within the specific chemical designation.
(e)    (1)   Unless specifically excepted under this subtitle or listed in another schedule, a material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system is a substance listed in Schedule I:
(i)   mecloqualone;
(ii)   methaqualone; and
(iii)   a salt, isomer, or salt of an isomer of a substance listed in this paragraph if the existence of the salt, isomer, or salt of an isomer is possible within the specific chemical designation.
(2)   Any material, compound, mixture, or preparation that contains any of the following substances is a substance listed in Schedule I:
(i)   3-methylfentanyl (N-3-methyl-1-(2-phenylethyl)-4-piperidyl-1-N-phenylpropanamide), its optical and geometric isomers, salts, and salts of isomers;
(ii)   acetyl-alpha-methylfentanyl;
(iii)   alpha-methylthiofentanyl;
(iv)   benzylfentanyl;
(v)   beta-hydroxy-3-methylfentanyl;
(vi)   beta-hydroxyfentanyl;
(vii)   thenylfentanyl;
(viii)   thiofentanyl; and
(ix)   3-methylthiofentanyl.
(f)    (1)   In this subsection:
(i)   “controlled dangerous substance analogue” means a substance:
1.   that has a chemical structure substantially similar to the chemical structure of a controlled dangerous substance listed in Schedule I or Schedule II; and
2.   that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled dangerous substance listed in Schedule I or Schedule II; but
(ii)   “controlled dangerous substance analogue” does not include:
1.   a controlled dangerous substance;
2.   a substance for which there is an approved new drug application; or
3.   a substance exempted for investigational use under § 506 of the Federal Food, Drug, and Cosmetic Act.
(2)   To the extent intended for human consumption, each controlled dangerous substance analogue is a substance listed in Schedule I.
(g)   The Department may not add a substance to Schedule I under § 5-202 of this title unless the Department finds:
(1)   a high potential for abuse of the substance;
(2)   no accepted medical use in the United States for the substance; and
(3)   a lack of accepted safety for use of the substance under medical supervision.